Vertex Partners with Ribometrix to Discover RNA-targeted Therapies
cystic fibrosis, News
Vertex Pharmaceuticals has entered a strategic collaboration with Ribometrix to discover potential RNA-targeted therapies for serious diseases. Vertex is a leader in the market of CFTR modulators for cystic fibrosis (CF), and is the ... Read more